ABSTRACT
OBJECTIVE@#To explore the mechanism of Radix Scrophulariae (RS) extracts in the treatment of hyperthyroidism rats by regulating proliferation, apoptosis, and autophagy of thyroid cell through the mammalian sterile 20-like kinase 1 (MST1)/Hippo pathway.@*METHODS@#Twenty-four rats were randomly divided into 4 groups according to a random number table: control, model group, RS, and RS+Hippo inhibitor (XMU-MP-1) groups (n=6 per group). Rats were gavaged with levothyroxine sodium tablet suspension (LST, 8 μ g/kg) for 21 days except for the control group. Afterwards, rats in the RS group were gavaged with RS extracts at the dose of 1,350 mg/kg, and rats in the RS+XMU-MP-1 group were gavaged with 1,350 mg/kg RS extracts and 1 mg/kg XMU-MP-1. After 15 days of administration, thyroid gland was taken for gross observation, and histopathological changes were observed by hematoxylin-eosin staining. The structure of Golgi secretory vesicles in thyroid tissues was observed by transmission electron microscopy. The expression of thyrotropin receptor (TSH-R) was observed by immunohistochemistry. Terminal-deoxynucleoitidyl transferase mediated nick end labeling assay was used to detect cell apoptosis in thyroid tissues. Real-time quantity primer chain reaction and Western blot were used to detect the expressions of MST1, p-large tumor suppressor gene 1 (LATS1), p-Yes1 associated transcriptional regulator (YAP), proliferating cell nuclear antigen (PCNA), G1/S-specific cyclin-D1 (Cyclin D1), B-cell lymphoma-2 (Bcl-2), Caspase-3, microtubule-associated proeins light chain 3 II/I (LC3-II/I), and recombinant human autophagy related 5 (ATG5). Thyroxine (T4) level was detected by enzyme-linked immunosorbent assay.@*RESULTS@#The thyroid volume of rats in the model group was significantly increased compared to the normal control group (P<0.01), and pathological changes such as uneven size of follicular epithelial cells, disorderly arrangement, and irregular morphology occurred. The secretion of small vesicles by Golgi apparatus was reduced, and the expressions of receptor protein TSH-R and T4 were significantly increased (P<0.01), while the expressions of MST1, p-LATS1, p-YAP, Caspase-3, LC3-II/I, and ATG5 were significantly decreased (P<0.01). The expressions of Bcl-2, PCNA, and cyclin D1 were significantly increased (P<0.01). Compared with the model group, RS extracts reduced the volume of thyroid gland, improved pathological condition of the thyroid gland, promoted secretion of the secretory vesicles with double-layer membrane structure in thyroid Golgi, significantly inhibited the expression of TSH-R and T4 levels (P<0.01), upregulated MST1, p-LATS1, p-YAP, Caspase-3, LC3-II/I, and ATG5 expressions (P<0.01), and downregulated Bcl-2, PCNA, and Cyclin D1 expressions (P<0.01). XMU-MP-1 inhibited the intervention effects of RS extracts (P<0.01).@*CONCLUSION@#RS extracts could inhibit proliferation and promote apoptosis and autophagy in thyroid tissues through MST1/Hippo pathway for treating hyperthyroidism.
Subject(s)
Rats , Humans , Animals , Hippo Signaling Pathway , Proliferating Cell Nuclear Antigen/metabolism , Cyclin D1/pharmacology , Caspase 3/metabolism , Protein Serine-Threonine Kinases/pharmacology , Apoptosis , Hyperthyroidism/drug therapy , Proto-Oncogene Proteins c-bcl-2/metabolism , Thyrotropin/pharmacology , Mammals/metabolismABSTRACT
Dopamine receptor type 3 (DRD3) expressed in the limbic system sites involved in the regulation of GnRH seems to play a role in neuroendocrine control. We hypothesized that women with chronic anovulation should show exacerbated secretion of prolactin (PRL) after thyrotropin-releasing hormone (TRH) stimulation test, having more chances for dopamine inhibitory dysfunction due to alterations in the structure of DRD3. The DRD3-coding region was evaluated in 60 women with chronic anovulation (35 without and 25 with hyperresponse of PRL after TRH stimulation), and in 34 controls. Statistically similar frequencies of homozygous AGC polymorphism (43.4 and 33.4%) and heterozygous polymorphism (33.4 and 47.9%) at position 9 were found in controls and patients, respectively. Homozygous GCG polymorphism at position 17 was identified in 3.4% Type 3 dopaminergic receptor in chronic anovulationof the patients, while heterozygosis occurred in 20.8% of the patients and in 6.6% of the controls. The novel 41563_41567delTAAGT polymorphismof DRD3 was identified in 14.7% of the controls and 8.6% of the women with chronic anovulation displaying hyperresponse of PRL after TRH stimulation. Alteration 41563_41567delTAAGT of DRD3 was not found in patients who did not show hyperresponse of PRL after TRH stimulation. Normal baseline and peak levels of PRL and thyroid-stimulating hormone were similar for women with and without 41563_41567delTAAGT in the DRD3 gene. It is concluded that the novel polymorphism in DRD3 identified in this study is not associated with the response of PRL to TRH stimulation in women with chronic anovulation.
Subject(s)
Humans , Female , Anovulation/genetics , Polymorphism, Genetic , /genetics , Anovulation/etiology , Case-Control Studies , Chronic Disease , Gene Frequency , Genotype , Prolactin , Thyrotropin/pharmacologyABSTRACT
Estradiol has well-known indirect effects on the thyroid. A direct effect of estradiol on thyroid follicular cells, increasing cell growth and reducing the expression of the sodium-iodide symporter gene, has been recently reported. The aim of the present investigation was to study the effect of estradiol on iodide uptake by thyroid follicular cells, using FRTL-5 cells as a model. Estradiol decreased basal iodide uptake by FRTL-5 cells from control levels of 2.490 0.370 to 2.085 0.364 pmol I-/æg DNA at 1 ng/ml (P<0.02), to 1.970 0.302 pmol I-/æg DNA at 10 ng/ml (P<0.003), and to 2.038 0.389 pmol I-/æg DNA at 100 ng/ml (P<0.02). In addition, 4 ng/ml estradiol decreased iodide uptake induced by 0.02 mIU/ml thyrotropin from 8.678 0.408 to 7.312 0.506 pmol I-/æg DNA (P<0.02). A decrease in iodide uptake by thyroid cells caused by estradiol has not been described previously and may have a role in goiter pathogenesis
Subject(s)
Animals , Rats , Estradiol/pharmacology , Iodides/metabolism , Thyroid Gland/cytology , Thyrotropin/pharmacology , Analysis of Variance , Cell Culture Techniques , Cells, Cultured , Statistics, Nonparametric , Thyroid Gland/drug effectsABSTRACT
Ceramide, a product of sphingomyelin hydrolysis, is now recognized as an intracellular lipid messenger, which mediates the effects of extracellular agents on cellular growth, differentiation and apoptosis. Recently, ceramide has been implicated in the regulation of phospholipase D (PLD). In this study, we examined the effects of ceramide on the activity and mRNA level of PLD during apoptotic process in FRTL-5 thyroid cells. C2-ceramide (N-acetyl sphingosine) induced apoptosis in FRTL-5 thyroid cells. Fluorescent staining showed that ceramide induced the typical features of apoptosis including condensed or fragmented nuclei. DNA fragmentation was also observed by agarose gel electrophoresis. Flow cytometric cell cycle analysis showed more clearly that ceramide induced apoptotic cell death in FRTL-5 thyroid cells. The treatment of FRTL-5 thyroid cells with thyroid-stimulating hormone (TSH) resulted in an increased PLD activity in a dose- and time-dependent manner. However, the TSH-induced increase in PLD activity was down-regulated within 2 h after ceramide treatment. Furthermore, the levels of PLD mRNA were found to be decreased throughout apoptotic process as inferred by reverse transcription-polymerase chain reaction. However, the decreases in PLD mRNA levels were not correlated with those in PLD activities after ceramide treatment. Taken together, these data suggest that ceramide inhibits the PLD activity in an early apoptotic phase and down-regulation of the levels of PLD mRNA may be implicated in apoptotic process in FRTL-5 thyroid cells.
Subject(s)
Rats , Animals , Apoptosis/drug effects , Cells, Cultured , DNA Fragmentation , Enzyme Activation/drug effects , Flow Cytometry , Gene Expression Regulation, Enzymologic/drug effects , Phospholipase D/metabolism , Phospholipase D/genetics , RNA, Messenger/genetics , Rats, Inbred Strains , Sphingosine/pharmacology , Sphingosine/analogs & derivatives , Thyroid Gland/enzymology , Thyroid Gland/drug effects , Thyrotropin/pharmacologyABSTRACT
This study was performed to prove the hypothesis that oncogene expressions would have the same patterns with those of cellular growth to growth factors in FRTL-5 cells. Ribonucleic acids of FRTL-5 were extracted at 15', 30', 60' and 120' after administration of growth factors to quiescent FRTL-5, and blotted to the nitrocellulose membrane. They were hybridized with radiolabelled c-fos, c-myc and beta-actin probes. Hybridized dot blots were autoradiographed and the amount of radioactivity was measured by densitometry. Densitometric readings were used as the indices of oncogene expressions. Expressions of c-fos and c-myc were more prominent in combined administrations of TSH (10 mU/ml) and IGF-I (100 ng/ml) or IgG of Graves' disease (Graves' IgG; 1 mg/ml) and IGF-I than in combined administration of TSH and Graves' IgG. IgG of primary myxedema suppressed oncogene expressions by TSH or Graves' IgG, but not by IGF-I. From the above results, it was suggested that expressions of c-fos and c-myc to growth factors would have similar patterns with those of cell growth to growth factors in FRTL-5, and the actions of TSH and Graves' IgG would be manifested through same signal transduction system, but IGF-I would be manifested by its own.
Subject(s)
Rats , Animals , Cell Division/drug effects , Cell Line/cytology , Gene Expression/drug effects , Graves Disease/immunology , Growth Substances/genetics , Immunoglobulin G/pharmacology , Insulin-Like Growth Factor I/pharmacology , Myxedema/immunology , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-myc/genetics , RNA/analysis , Rats, Inbred F344 , Thyroid Gland/cytology , Thyrotropin/pharmacology , Time FactorsABSTRACT
El aumento sérico de la hormona hipofisaria estimulante de la función tiroides (TSH) como respuesta al estimulo de la aplicación endovenosa de la hormona hipotalámica estimulante de la secreción de TSH (TRH) ha sido utilizada como prueba de valoración de la función hipofisaria en su secreción de TSH. Se estudian 147 niños entre 4 años, 14 años 6 meses referidos por diferentes patologías al Servicio de Endocrinología del Hospital Nacional de Niños Dr. Carlos Sáenz Herrera. En todos ellos la función del eje hipotálamo-tiroideo fue normal. A todos los niños se les determinó el nivel sérico del TSH mediante RIA a 0-30-60 y 90 minutos después de aplicar 200 micron de TRH/m2 de superficie corporal vía endovenosa. Los niveles de TSH basales de 3,8ñ1,8micron UI/ml (1DS) coinciden con lo reportado en la literatura y con el trabajo previo realizado en nuestro Laboratorio. Posterior a la aplicación del TRH endovenoso se obtiene una elevación del TSH que en la mayoria de los casos se presenta alrededor del minuto 30 pero que puede encontrarse en condiciones normales en cualquier tiempo de la prueba. Para el estudio de la respuesta utilizamos el incremento concluyendo que todo incremento inferior a 9,3micronUI/ml o superior a 21,7 micronUI/ml debe ser considerado como anormal
Subject(s)
Child, Preschool , Child , Adolescent , Humans , Pituitary Hormones , Thyrotropin/pharmacology , Growth , Thyroid Gland , Hypothalamic HormonesABSTRACT
Foram estudadas cinco pacientes eutiroidianas portadores de nódulos autônomos à cintilografia tireiodiana, com diàmetro superio a 3cm e näo supressíveis pela administraçäo de T, (100µg/dia durante 10 dias). Quatro das pacientes apresentaram exames laboratoriais (T4 livre, T3 TSH basal e captaçäo de 131I em 24h) normais. Fatias de tecido tireoidiano adenomatoso e paranodular obtidas pela tiroidectomia foram incubadas com concentraçöes crescentes de TSH e na presença ou näo de iodeto de potássio (KI)ou triiodotironina (T3). O incremento da produçäo de AMP cíclico (cAMP) provocado pelo TSH no tecido adenomatoso foi igual ao encontrado do tecido adjacente paranodular. No tecido paranodular a adiçäo de T3 ou KI inibiu significativamente a produçäo de cAMP, enquanto que, no tecido adenomatoso, a açäo inibitória ocorreu apenas com KI. Estes resultados sugerem: 1) a inibiçäo da secreçäo pode ocorrer na presença de níveis hormonais tiroidianos circulantes normais; 2) nâo há evidência de sensibilidade aumentada ao TSH no tecido autônomo quando avaliada pela produçäo de cAMP; 3) a ausência inibitória do T, na resposta do TSH no tecido nodular sugere alteraçäo celular ao nível de outros reguladores da geraçäo de cAMP.